Stepan Company Delivers Robust Q2 2026 Earnings, Announces Workforce Reduction and Strategic Initiatives
Second Quarter 2026 Key Highlights
- Net Income Surges: Reported net income for Q2 2026 was \$22.9 million, up 102% from the prior year. Adjusted net income reached \$27.1 million, a 126% increase.
- EBITDA Growth: EBITDA climbed to \$69.1 million (+37%), and Adjusted EBITDA hit \$74.4 million (+45%).
- Sales Volume Increases: Global sales volume rose 3% year-over-year, with organic sales volume up 6%.
- Cash Flow Dynamics: Cash from operations was \$8.4 million. Free cash flow was negative at \$15.0 million, impacted by higher working capital requirements; excluding this, free cash flow would have been a positive \$32.7 million (+69% y/y).
- Restructuring Charge: Pre-tax earnings included a \$5.1 million restructuring charge, mainly tied to the closure of the Fieldsboro, NJ site and decommissioning of assets at Elwood (Millsdale), IL and Stalybridge, UK.
Strategic Restructuring and Project Catalyst
- Salaried Workforce Reduction: The company announced a plan to reduce its global salaried workforce by about 100 positions as part of Project Catalyst, aimed at organizational effectiveness and efficiency gains. Most restructuring expenses will be recognized in the second half of 2026.
- Financial Impact: Full-year restructuring charges are expected in the range of \$75.0–\$80.0 million, with a projected cash impact of \$14.0–\$18.0 million.
First Half 2026 Performance
- Net Loss on Reported Basis: The company posted a net loss of \$18.5 million for H1 2026, versus net income of \$31.1 million in the previous year, entirely due to a \$70.5 million pre-tax restructuring charge. The cash outlay related to this was \$7.0 million year-to-date.
- Adjusted Net Income: Adjusted net income for H1 2026 was \$37.4 million, up 20% year-over-year.
- EBITDA Trends: EBITDA for H1 2026 was \$52.7 million, with Adjusted EBITDA at \$124.1 million (+14%).
- Organic Sales Volume: Up 3% year-over-year.
Segment Performance
Q2 2026 Segment Revenue and Performance
- Surfactants: Net sales were \$483.9 million (+18%), with global sales volume up 2% and organic sales volume up 7%. Adjusted EBITDA jumped 59% to \$54.9 million. Price increases (+12%) were mainly the result of higher raw material costs passed through, improved mix, and targeted pricing actions. All regions saw organic volume growth.
- Polymers: Net sales were \$178.0 million (+9%), with 5% higher sales volume and 3% higher average selling prices. Double-digit North American volume growth (particularly in Rigid and Phthalic Anhydride) offset weaker European and Asian volumes. Adjusted EBITDA grew 22% to \$31.2 million.
- Specialty Products: Net sales were \$22.2 million (+8%); volume up 4%, but adjusted EBITDA fell 3% to \$6.5 million due to product mix shifts in medium chain triglycerides, partially offset by growth in food and flavor products.
Consolidated Financial Performance
- Total Net Sales: \$684.1 million for Q2 2026 (+15%), and \$1.29 billion for H1 2026 (+8%).
- Operating Income: \$37.2 million for Q2 (+107%), but a loss of \$12.4 million for H1 due to restructuring charges.
- Earnings per Share: Q2 EPS was \$1.00 (diluted), up from \$0.50. Adjusted EPS was \$1.18, up 127%.
- Balance Sheet: Total assets were \$2.39 billion as of June 30, 2026. Net debt increased to \$533.7 million (net debt ratio: 31%).
Important Details for Shareholders (Price Sensitive Information)
- Major Restructuring: The closure of the Fieldsboro, NJ site, decommissioning at Millsdale, IL and Stalybridge, UK, and the announced workforce reduction are significant cost-cutting and efficiency measures. These will impact short-term earnings but are expected to position the company for improved profitability and cash flow in future periods.
- Project Catalyst Progress: Execution remains in line with expectations. The company aims to create a more agile and productive organization, potentially boosting long-term margins and supporting future growth.
- Improved Earnings and Margins: Significant year-over-year improvements in adjusted net income and EBITDA, especially in Surfactants and Polymers, signal a recovery in demand and effective margin management.
- Cash Flow Pressures: Negative free cash flow in Q2 due to working capital requirements, but underlying cash generation remains strong when adjusted for this.
- Forward Guidance: Management expects to deliver full-year adjusted EBITDA growth, positive free cash flow, and further balance sheet deleveraging in 2026, despite global economic uncertainty.
- Risks: Execution risks tied to restructuring, potential operational disruptions, global macroeconomic uncertainty, and supply chain challenges are highlighted in the company’s forward-looking statements.
Management Commentary
“Quarterly earnings were up significantly driven by improved Surfactant and Polymer results. Q2 adjusted EBITDA of \$74.4 million was up 45% year-over-year due to global volume growth, margin recovery and Project Catalyst savings. Surfactant and Polymer adjusted EBITDA were up 59% and 22%, respectively. Surfactant organic sales volume was up 7% and Polymer sales volume was up 5% in the quarter. Growth was broad-based, with North American Polymers seeing double-digit volume increases.
As part of Project Catalyst, we’ve taken a disciplined approach to workforce reductions, supporting our affected colleagues in line with our People First culture. With the strong first half results, we believe we will deliver full-year Adjusted EBITDA growth, positive free cash flow and continue to de-leverage the balance sheet in 2026.”
– Luis E. Rojo, President and CEO
Outlook
- Stepan expects to continue delivering growth in core strategic markets such as Crop Productivity, Oilfield, Tier 2/3 Surfactants, and North American Polymers.
- Execution of Project Catalyst remains a priority, with ongoing efforts to optimize the asset base and enhance organizational agility.
- Management remains focused on productivity, growth opportunities, and cash flow interventions to support financial health and shareholder value.
Conference Call and Additional Information
- A conference call to discuss Q2 results will be held on July 29, 2026, at 9:00 a.m. ET. Details and supporting materials are available on the company’s investor website.
- Stepan Company is a leading global manufacturer of specialty and intermediate chemicals, particularly surfactants and polyurethane polyols for the thermal insulation and CASE markets.
Disclaimer
This article contains a summary of Stepan Company’s financial results and outlook as reported for the second quarter of 2026. It includes forward-looking statements and is provided for informational purposes only and does not constitute investment advice. Actual results may differ materially due to risks and uncertainties as detailed in the company’s filings. Investors should perform their own due diligence and consult a qualified financial advisor before making investment decisions.
